With some biological threats mitigated, US BARDA shifts focus to combat highly pathogenic viruses, chemical agents


The US Biomedical Advanced Research and Development Authority (BARDA) intends to ramp up investment in medical countermeasures for viral hemorrhagic fevers and chemical threat agents.

Content Information

Content Author: 
unknown
Content Source: 
Homeland Preparedness News
Content Type: 
News